Prospective observational study of Idiopathic pulmonary fibrosis with Non-small-cell lung cancer(LOGIK0603) - Prospective observational study of Idiopathic pulmonary fibrosis with Non-small-cell lung cancer(LOGIK0603)

ung Oncology Group in Kyushu, Japan (LOGIK)0 个研究点目标入组 60 人开始时间: 2014年12月12日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients with suspicion of exacerbation of idiopathic pulmonary fibrosis (increase in such as LDH, KL-6, SP-A, SP-D, so on). 2) Patient with superior vena cava syndrome. 3) Patient with the history of severe drug allergy. 4) Patient with pleural effusion, ascites, and pericardial effusion need for treatment of such as drainage. 5) Patient with severe infection and other severe complications (gastrointestinal hemorrhage, heart disease, etc). 6) Patient with symptomatic brain metastasis. 7) Patients with steroid administration. 8) Patient with active double cancer. 9) Patient with diabetes hard to control. 10) Unstable psychic disorder. 11) Pregnant or breast-feeding females. 12) Inappropriate patients for this study judged by the physicians. In group B, to confirm hypersensitivity to polyoxyethylene castor oil (Cremophor EL) product (such as cyclosporine), curing caster oil product (such as injectable vitamin), and alcohol hypersensitivity.

发起方

ung Oncology Group in Kyushu, Japan (LOGIK)